Gossamer Bio (GOSS)
(Delayed Data from NSDQ)
$0.91 USD
+0.02 (1.98%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $0.91 0.00 (0.14%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.91 USD
+0.02 (1.98%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $0.91 0.00 (0.14%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Zacks News
Gossamer Bio (GOSS) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Gossamer Bio (GOSS) delivered earnings and revenue surprises of -4.35% and 40.10%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Gossamer Bio (GOSS) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Gossamer Bio (GOSS) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Gossamer Bio (GOSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Gossamer Bio (GOSS) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Gossamer Bio (GOSS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
What Makes Gossamer Bio (GOSS) a New Buy Stock
by Zacks Equity Research
Gossamer Bio (GOSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Gossamer Bio (GOSS) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Gossamer Bio (GOSS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts See a 52% Upside in Gossamer Bio (GOSS): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 52.4% in Gossamer Bio (GOSS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Believe Gossamer Bio (GOSS) Could Rally 113%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Gossamer Bio (GOSS) points to an 113.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Gossamer Bio (GOSS) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Gossamer Bio (GOSS), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Are Options Traders Betting on a Big Move in Gossamer Bio (GOSS) Stock?
by Zacks Equity Research
Investors need to pay close attention to Gossamer Bio (GOSS) stock based on the movements in the options market lately.
Gossamer Bio's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Gossamer Bio.
New Strong Buy Stocks for May 8th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Bet on Rising P/E Investing With These Top 5 Stocks
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
Will Gossamer Bio Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Gossamer Bio
Why Gossamer Bio (GOSS) Stock Might be a Great Pick
by Zacks Equity Research
Gossamer Bio (GOSS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Implied Volatility Surging for Gossamer Bio (GOSS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Gossamer Bio (GOSS) stock based on the movements in the options market lately.